In the present study, we further explored the involvement of the PSGR in prostate cancer progression and tried to counteract its promoting effect on metastasis occurrence and dissemination using α-ionone, an odorant molecule reported as a PSGR antagonist [26]. The gene discussed is OR51E2; the disease is prostate carcinoma.